Minerva Neurosciences, Inc. (NERV) has a consensus analyst rating of Buy, based on 7 analysts covering the stock. Of those, 5 recommend buying, 2 recommend holding, and 0 recommend selling.
The analyst consensus price target for NERV is $5.00, representing a -19.1% downside from the current price of $6.18. Price targets range from a low of $5.00 to a high of $5.00.
